IP Library Granted Patent US 10,653,681
Granted Patent B2
US 10,653,681 · App. 16/085,505 · Granted May 19, 2020

Analgesic compounds

Inventors: Kevin Duane Bunker (Escondido, CA); Deborah Helen Slee (Encinitas, CA); Chad Daniel Hopkins (San diego, CA); Joseph Robert Pinchman (San Diego, CA); Mehmet Kahraman (San Diego, CA); Peter Qinhua Huang (San Diego, CA)
Assignee: Recurium IP Holdings, LLC
A61K31/433A61K31/136A61K31/137A61K31/165A61K31/167A61K31/415A61K31/421A61K31/426A61K31/4245A61K31/44A61K31/505A61P29/00C07C211/29C07C211/52C07C233/07C07C233/13C07C233/15C07C233/25C07D213/38C07D213/73C07D231/12C07D233/12C07D239/42C07D263/48C07D271/113C07D277/28C07D277/32C07D277/40C07D277/42C07D285/08C07D285/12C07D285/125C07D285/135A61K9/0019A61K9/0053A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,681
App. No.
16/085,505
Granted
May 19, 2020
Kind
B2
Abstract

Disclosed herein are compounds of Formula (I), methods of synthesizing compounds of Formula (I), and methods of using compounds of Formula (I) as an analgesic.

Claims (14)

1. A method for reducing or at least partially preventing pain or fever comprising administering an effective amount of a medicament comprising any of the compound selected from the group consisting of:

or

a pharmaceutically acceptable salt of any of the foregoing.

2. The method of claim 1 , further comprising administering an opioid analgesic in combination.

3. The method of claim 2 , wherein the opioid analgesic is selected from the group consisting of morphine, codeine, hydrocodone, oxycodone, fentanyl, pethidine, methadone, pentazocine, sufentanil, levorphanol, dihydrocodeine, nalbuphine, butorphanol, tramadol, meptazinol, buprenorphine, dipipanone, alfentanil, remifentanil, oxymorphone, tapentadol, propoxyphene and hydromorphone.

4. The method of claim 1 , wherein the compound is administered intravenously, administered orally or administered intraperitoneally.

5. The method of claim 1 , wherein the pain is acute pain.

6. The method of claim 1 , wherein the pain is post-operative pain.

7. The method of claim 1 , wherein the pain is chronic pain.

8. The method of claim 1 , wherein the pain is nociceptive pain.

9. The method of claim 1 , wherein the pain is selected from the group consisting of osteoarthritis pain, rheumatoid arthritis pain, migraine pain, lower back pain, cancer pain and fibromyalgia pain.

10. The method of claim 1 , wherein the pain is neuropathic pain.

11. The method of claim 1 , wherein the pain is visceral pain.

12. The method of claim 1 , wherein the pain is mixed pain.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2025
From: RECURIUM IP HOLDINGS, LLC
To: KTHERA, LLC
Reel/Frame 070653/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2020
From: BUNKER, KEVIN DUANE; SLEE, DEBORAH HELEN; HOPKINS, CHAD DANIEL; PINCHMAN, JOSEPH ROBERT; KAHRAMAN, MEHMET; HUANG, PETER QINHUA
To: KALYRA PHARMACEUTICALS, INC.
Reel/Frame 051409/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2020
From: KALYRA PHARMACEUTICALS, INC.
To: ZENO ROYALTIES & MILESTONES, LLC
Reel/Frame 051411/0421 →
CHANGE OF NAME Recorded Jan 3, 2020
From: ZENO ROYALTIES & MILESTONES, LLC
To: RECURIUM IP HOLDINGS, LLC
Reel/Frame 051477/0802 →
Continuity (2)
Provisional Application 62309338 · Mar 16, 2016
Related Publication 20190111031A1 · Apr 18, 2019